These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16320017)

  • 1. [Effects of drugs on the adrenal cortex and its tumors].
    Saeger W; Fassnacht M
    Pathologe; 2006 Feb; 27(1):61-4. PubMed ID: 16320017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the adrenal cortex: clinical description, diagnosis, and treatment.
    Plager JE
    Int Adv Surg Oncol; 1984; 7():329-53. PubMed ID: 6088397
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
    Kerkhofs TM; Baudin E; Terzolo M; Allolio B; Chadarevian R; Mueller HH; Skogseid B; Leboulleux S; Mantero F; Haak HR; Fassnacht M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4759-67. PubMed ID: 24057287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglutethimide in the treatment of Cushing's syndrome.
    Misbin RI; Canary J; Willard D
    J Clin Pharmacol; 1976; 16(11-12):645-51. PubMed ID: 993360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant mitotane for adrenocortical cancer--a recurring controversy.
    Huang H; Fojo T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3730-2. PubMed ID: 18842984
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma.
    Schteingart DE; Sinsheimer JE; Counsell RE; Abrams GD; McClellan N; Djanegara T; Hines J; Ruangwises N; Benitez R; Wotring LL
    Cancer Chemother Pharmacol; 1993; 31(6):459-66. PubMed ID: 8453685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant mitotane for adrenocortical cancer--working through uncertainty.
    Terzolo M; Fassnacht M; Ciccone G; Allolio B; Berruti A
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1879-80. PubMed ID: 19494162
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast.
    Santen RJ; Wells SA
    Cancer; 1980 Aug; 46(4 Suppl):1066-74. PubMed ID: 6249490
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mitotane in the treatment of adrenal carcinoma].
    Sane T
    Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer.
    Terzolo M; Pia A; Berruti A; Osella G; Alì A; Carbone V; Testa E; Dogliotti L; Angeli A
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2234-8. PubMed ID: 10852456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of o,p'-DDD and Li+ on apoptotic DNA fragmentation in conventionally normal and tumour tissues of human adrenal cortex.
    Pushkarev VM; Tronko ND; Kostyuchenko NN; Mikosha AS
    Ukr Biokhim Zh (1999); 2007; 79(2):44-9. PubMed ID: 18030749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study.
    Zsippai A; Szabó DR; Tömböl Z; Szabó PM; Eder K; Pállinger E; Gaillard RC; Patócs A; Tóth S; Falus A; Rácz K; Igaz P
    Pharmacogenomics; 2012 Sep; 13(12):1351-61. PubMed ID: 22966885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant mitotane therapy of adrenal cancer - use and controversy.
    Schteingart DE
    N Engl J Med; 2007 Jun; 356(23):2415-8. PubMed ID: 17554125
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural changes of the adrenal cortex in Cushing's syndrome treated with aminoglutethimide (Elipten Ciba).
    Marek J; Motlik K
    Virchows Arch B Cell Pathol; 1975; 18(2):145-56. PubMed ID: 807031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals.
    Moore RN; Penney DP; Averill KT
    Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenocortical carcinoma.
    Barzilay JI; Pazianos AG
    Urol Clin North Am; 1989 Aug; 16(3):457-68. PubMed ID: 2665272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.